May 13 (SeeNews) - Slovenian drug maker Krka [LJE:KRKG] said on Tuesday that the Oslo supreme court has rejected its leave to appeal in the proceedings for alleged infringement of a patent that protects esomeprazole, a proton pump inhibitor, with a high optical purity.